藥房市場規模、佔有率和成長分析（按藥房、產品供應、可及性、藥物類型、藥物分子類型和地區分類）－2026-2033年產業預測

預計到 2024 年，全球醫藥市場規模將達到 1.25 兆美元，到 2025 年將達到 1.34 兆美元，到 2033 年將達到 2.36 兆美元，在預測期（2026-2033 年）內，複合年成長率為 7.3%。

由於慢性病盛行率上升、醫療保健需求不斷成長以及藥物研發和技術進步，全球藥房市場正在快速發展。個人化醫療的需求顯著增加，學名藥日益普及，線上藥局也蓬勃發展。儘管存在這些積極趨勢，但該行業仍面臨著許多挑戰，例如嚴格的監管要求、高昂的研發成本以及價格壓力。然而，也存在著許多機遇，包括數位健康解決方案和遠端醫療服務的成長、對預防保健的日益重視以及發展中地區市場的快速成長。透過適應這些變化的環境和消費者需求，藥房產業有望實現顯著成長。

推動全球藥局市場發展的因素

生物技術的進步正推動著針對各種健康狀況的更可靠、更有效的藥物的研發，尤其是在生物相似藥和生物製藥領域。此外，個人化基因資訊日益重要，也帶動了對個人化藥物和醫療產品的需求。這些發展，加上患者對更精準、更有效的治療方案的需求不斷變化，正推動著全球藥房市場顯著成長，而個人化醫療的日益普及正是這一成長的主要驅動力。因此，藥房市場正經歷著變革時期。

限制全球醫藥市場的因素

研發和上市新藥的高昂成本會阻礙中小企業進入市場，並限制整個製藥業的成長。研發和監管核准所需的大量投資構成准入壁壘，限制了競爭和創新。此外，許多候選藥物在臨床試驗階段失敗，對相關公司造成重大經濟損失。這些高成本，加上結果的不確定性，為中小企業帶來了嚴峻的挑戰，最終影響全球醫藥市場的格局。

全球醫藥市場趨勢

在全球基因組檢測和標靶治療進步的推動下，全球醫藥市場正經歷著向個人化醫療的重大轉變。這種轉變在慢性病和腫瘤治療領域尤其明顯，個人化治療方案在這些領域的重要性日益凸顯。此外，生物相似藥和生物製藥的興起為複雜的健康狀況提供了更多個人化的治療選擇，並改善了患者的整體預後。隨著精準醫療在醫療保健領域的重要性日益凸顯，對個人化醫療的需求預計將進一步成長，這將重塑藥學實踐，並擴大藥劑師在患者照護中的作用。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 技術分析

全球藥局市場規模：依藥局類型及複方年成長率分類（2026-2033 年）

• 零售藥房
• 網路藥房
• 醫院藥房
• 其他藥房

全球藥局市場規模（依產品供應量及複合年成長率分類）（2026-2033 年）

• 藥品/製劑
• 醫療設備
• 其他藥房產品

全球藥局市場規模：按類型分類的供應情況及複合年成長率（2026-2033 年）

• 處方箋藥
• 非處方藥

全球藥局市場規模（依藥品類型及複方年成長率分類）（2026-2033 年）

• 品牌藥/專利藥
• 學名藥

全球藥局市場規模（依藥物分子類型分類）及複合年成長率（2026-2033 年）

• 小分子藥物
• 生物製藥

全球藥局市場規模（按網路藥局平台類型和複合年成長率分類）（2026-2033 年）

• 基於應用程式的平台
• 網路為基礎的平台

全球藥局市場規模（依治療領域分類）及複合年成長率（2026-2033 年）

• 腫瘤性疾病
• 循環系統疾病
• 神經系統疾病
• 感染疾病
• 代謝性疾病
• 呼吸系統疾病
• 皮膚病
• 遺傳性疾病
• 自體免疫疾病/發炎性疾病
• 其他疾病

全球藥局市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• CVS Health Corporation（USA）
• AmerisourceBergen Corporation（USA）
• McKesson Corporation（USA）
• Cardinal Health, Inc.（USA）
• Rite Aid Corporation（USA）
• OptumRx, Inc.（USA）
• Humana Inc.（USA）
• Groupe Pharmagest SA（France）
• MedImpact Healthcare Systems, Inc.（USA）
• AllianceRx Walgreens Prime（USA）
• Benzer Pharmacy（USA）
• Kroger Health（USA）
• HealthWarehouse.com, Inc.（USA）

結論與建議

Global Pharmacy Market size was valued at USD 1.25 Trillion in 2024 and is poised to grow from USD 1.34 Trillion in 2025 to USD 2.36 Trillion by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).

The global pharmacy market is rapidly evolving, fueled by the increasing prevalence of chronic illnesses, heightened healthcare demands, and advancements in pharmaceutical research and technology. There is a substantial rise in the need for personalized medications, the popularity of generic drugs, and the expansion of online pharmacies. Despite these positive trends, the industry faces challenges including strict regulatory requirements, high research and development costs, and pricing pressures. Nonetheless, opportunities abound, particularly with the growth of digital health solutions and telehealth services, an increasing focus on preventive care, and a burgeoning market in developing regions. The pharmacy sector is poised for significant growth as it adapts to these changing dynamics and consumer needs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmacy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmacy Market Segments Analysis

Global Pharmacy Market is segmented by Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of E-PharmacyPlatform, Therapeutic Area and region. Based on Pharmacy, the market is segmented into Retail Pharmacy, e-pharmacy, Hospital Pharmacy and Other Pharmacies. Based on Product Offered, the market is segmented into Drugs / Pharmaceuticals, Medical Devices and Other Pharmacy Products. Based on Availability, the market is segmented into Prescription Products and Over-the-counter Products. Based on Type of Drug, the market is segmented into Branded / Patented Drugs and Generic Drugs. Based on Type of Drug Molecule, the market is segmented into Small Molecules and Biologics. Based on Type of e-pharmacy Platform, the market is segmented into App-based Platforms and Web-based Platforms. Based on Therapeutic Area, the market is segmented into Oncological Disorders, Cardiovascular Disorders, Neurological Disorders, Infectious Diseases, Metabolic Disorders, Respiratory Disorders, Dermatological Disorders, Genetic Disorders, Autoimmune / Inflammatory Disorders and Other Disorders. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmacy Market

Advancements in biotechnology are leading to an increase in drug developments, particularly in the areas of biosimilars and biologics, which demonstrate enhanced reliability and effectiveness for various health conditions. Additionally, the rising significance of personalized genetic information is influencing the demand for tailored medications and healthcare products. These developments are driving substantial growth in the global pharmacy market, as a greater focus on individualized treatment options aligns with the evolving needs of patients seeking more precise and effective therapeutic solutions. As such, the pharmacy market is experiencing a transformative phase marked by innovation and customization.

Restraints in the Global Pharmacy Market

The high expenses associated with the development and launch of new pharmaceuticals can deter smaller companies from entering the market, potentially hindering overall growth within the pharmaceutical sector. The substantial investment required for research, development, and regulatory approval can be a barrier to entry, limiting competition and innovation. Additionally, the reality that a significant percentage of drug candidates fail during clinical trials results in considerable financial setbacks for companies involved. This combination of high costs and uncertain outcomes creates a challenging environment for smaller players, ultimately affecting the dynamics of the global pharmacy market.

Market Trends of the Global Pharmacy Market

The global pharmacy market is witnessing a significant trend towards personalized medicine, driven by advancements in genomics testing and targeted therapies. This shift is particularly prominent in the management of chronic diseases and oncology, where individualized treatment approaches are becoming increasingly essential. Furthermore, the rise of biosimilars and biologics is enhancing the availability of tailored treatment options, catering to complex health conditions and improving overall patient outcomes. As healthcare increasingly prioritizes precision medicine, the demand for customized therapies is expected to grow, reshaping pharmacy practices and expanding the role of pharmacists in patient care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Analysis

Global Pharmacy Market Size by Pharmacy & CAGR (2026-2033)

• Market Overview
• Retail Pharmacy
• e-pharmacy
• Hospital Pharmacy
• Other Pharmacies

Global Pharmacy Market Size by Product Offered & CAGR (2026-2033)

• Market Overview
• Drugs / Pharmaceuticals
• Medical Devices
• Other Pharmacy Products

Global Pharmacy Market Size by Availability & CAGR (2026-2033)

• Market Overview
• Prescription Products
• Over-the-counter Products

Global Pharmacy Market Size by Type of Drug & CAGR (2026-2033)

• Market Overview
• Branded / Patented Drugs
• Generic Drugs

Global Pharmacy Market Size by Type of Drug Molecule & CAGR (2026-2033)

• Market Overview
• Small Molecules
• Biologics

Global Pharmacy Market Size by Type of e-pharmacy Platform & CAGR (2026-2033)

• Market Overview
• App-based Platforms
• Web-based Platforms

Global Pharmacy Market Size by Therapeutic Area & CAGR (2026-2033)

• Market Overview
• Oncological Disorders
• Cardiovascular Disorders
• Neurological Disorders
• Infectious Diseases
• Metabolic Disorders
• Respiratory Disorders
• Dermatological Disorders
• Genetic Disorders
• Autoimmune / Inflammatory Disorders
• Other Disorders

Global Pharmacy Market Size & CAGR (2026-2033)

• North America (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • US
  • Canada
• Europe (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• CVS Health Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AmerisourceBergen Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rite Aid Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OptumRx, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Humana Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Groupe Pharmagest S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedImpact Healthcare Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AllianceRx Walgreens Prime (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Benzer Pharmacy (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kroger Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HealthWarehouse.com, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations